http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2176505-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ca9a10a8ae638bf0bd91fbbe3ed26ad
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8055fb00a3b90070ecb00c256fce9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a17863b2beca77779bfbc40d00b5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f92763409fa396db7825712a72a6619
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75e6277266c87f556a363e3ed2498a7
publicationDate 2001-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2176505-C2
titleOfInvention Agent based on silver and gold compounds with thiazine with antiviral activity and method of its preparing
abstract FIELD: metalloorganic compounds, medicine. SUBSTANCE: invention relates to water-soluble antiviral agent based on silver and gold compounds with N, N 1 -tetramethylthiazine nitrate in the mole ratio 1:1:2, respectively, and corresponding to the formula C 32 H 36 N 9 O 9 S 2 -ClAgAu. Method of synthesis of agent involves addition of silver nitrate to N,N 1 -tetramethylthiazine chloride an aqueous solution heated to 80-95 C in the mole ratio = 1:1 and formed precipitate is filtered off. Then to solution at 80-95 C silver nitrate an aqueous solution is added followed by addition of gold compound in the form of gold trichloride or chloroauric acid trihydrate and ethyl alcohol in the mole ratio = 2:1:1:1, respectively, and prepared solution is fed for drying. EFFECT: simplified process, realization of proposed agent. 2 cl, 5 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005054217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110389-A1
priorityDate 2000-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129701581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452754495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453277883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454497505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15789245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449391796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448708270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449097368

Total number of triples: 47.